Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/26/1995 | EP0663911A1 Benzopyranones, method of preparing them and their use. |
07/26/1995 | EP0663909A1 Method of obtaining 10-deacetylbaccatine iii. |
07/26/1995 | EP0663907A1 Method of preparing taxane derivatives. |
07/26/1995 | EP0663906A1 Method of preparing taxane derivatives. |
07/26/1995 | EP0663903A1 1,2-dihydro-2-oxo-3-amino quinoxaline derivatives, preparation thereof and application in therapy. |
07/26/1995 | EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
07/26/1995 | EP0663900A1 Metal-oxime chelates for use as radiopharmaceutical agents |
07/26/1995 | EP0663899A1 Substituted kynurenines, a process for their preparation, and use as medicaments |
07/26/1995 | EP0663839A1 Ibuprofen-h 2? antagonist combinations |
07/26/1995 | EP0663832A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
07/26/1995 | EP0663831A1 Transdermal azidothymidine |
07/26/1995 | EP0663830A1 Method of treating lung disease with uridine triphosphates |
07/26/1995 | EP0663829A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
07/26/1995 | EP0663828A1 Compositions for treating allergic disorders using (-) cetirizine |
07/26/1995 | EP0663827A1 Tocolytic oxytocin receptor antagonists |
07/26/1995 | EP0663826A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
07/26/1995 | EP0663825A1 Use of melatonin to induce sleep |
07/26/1995 | EP0663824A1 Potassium channel activating compounds and methods of use thereof |
07/26/1995 | EP0663823A1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
07/26/1995 | EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
07/26/1995 | EP0663819A1 Ibuprofen-caffeine combinations |
07/26/1995 | EP0663816A1 Novel class of phosphocholine derivatives having antifungal activity |
07/26/1995 | EP0663812A1 Use of alkylpolyglycosides and/or o-acylated derivatives of glucose for treating hair loss. |
07/26/1995 | EP0638101A4 Synthetic melanin. |
07/26/1995 | EP0630181A4 Nutritional product for trauma and surgery patients. |
07/26/1995 | EP0596929B1 Amide derivatives of antibiotic a 40926 |
07/26/1995 | EP0594570B1 Preparations containing colestyramine for reducing lipid levels |
07/26/1995 | EP0565721B1 1,4-benzothiazepine derivative |
07/26/1995 | EP0536197B1 Pure crystalline form of rifapentine |
07/26/1995 | EP0527891B1 Biodegradable polyesters for sustained drug delivery |
07/26/1995 | EP0502092B1 Oral composition for the treatment of inflammatory bowel diseases |
07/26/1995 | EP0416037B1 Superoxide dismutase analogs having novel binding properties |
07/26/1995 | CN1105669A Compound used as bone targetted drug with estrin structure |
07/26/1995 | CN1105666A Novel diazabicycloalkenes and processes for the preparation thereof |
07/26/1995 | CN1105563A Antibiotic combination |
07/26/1995 | CN1105562A Methyl benzoate cream |
07/26/1995 | CN1105561A Thrapeutic composition and method of using same for treatment of hangover |
07/26/1995 | CA2140701A1 Liposome solutions |
07/25/1995 | US5436401 Skin disorders |
07/25/1995 | US5436400 Isolation and structure of spongistatin 1 |
07/25/1995 | US5436369 Alicyclic phospholipase A2 inhibitors |
07/25/1995 | US5436355 Parasiticdes, bactericides |
07/25/1995 | US5436348 Sleep disorders |
07/25/1995 | US5436343 Thromboxane A2 receptor antagonist, thromoboxane A2 synthase inhibitor |
07/25/1995 | US5436342 Cardiovascular disorders and muscular disorders |
07/25/1995 | US5436341 Intermediates for 2,3-diamino-1,5-iminosugars |
07/25/1995 | US5436337 Anticarcinogenic agents |
07/25/1995 | US5436273 Psychoactive propargylamine derivatives used in the treatment of anxiety, psychotic states or aggression |
07/25/1995 | US5436272 Treatment of obesity |
07/25/1995 | US5436270 Administering arginine for bactericides and shock treatment |
07/25/1995 | US5436269 Method for treating hepatitis |
07/25/1995 | US5436266 Compounds |
07/25/1995 | US5436263 Inhibit farnesylation of oncogene protein Ras |
07/25/1995 | US5436262 Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane |
07/25/1995 | US5436261 Benzospiroalkene heterocyclic compounds |
07/25/1995 | US5436258 Prevention of bone resorption |
07/25/1995 | US5436257 Low toxicity |
07/25/1995 | US5436255 Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
07/25/1995 | US5436253 Pyridonecarboxylic acid derivatives and mycotic infections |
07/25/1995 | US5436252 5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders |
07/25/1995 | US5436251 Treating neuro-psychiatric disorders gastrointenstinal disorders or migranes |
07/25/1995 | US5436247 Antiinflammatory agents or antiarthritic agents |
07/25/1995 | US5436246 Serotonin receptor agents |
07/25/1995 | US5436245 Phosphate substituted amino or imino acids useful as antihypertensives |
07/25/1995 | US5436244 Antiarrhythmia agents |
07/25/1995 | US5436243 Aminoanthraquinone derivatives to combat multidrug resistance |
07/25/1995 | US5436242 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation |
07/25/1995 | US5436241 Topical anti-inflammatory compositions containing piroxicam |
07/25/1995 | US5436239 Administering a platelet activating factor inhibitor |
07/25/1995 | US5436235 3-aryl-glycidic ester derivatives |
07/25/1995 | US5436234 Eurcyl, brassidyl and nervonyl derivatives |
07/25/1995 | US5436233 Nervous system disorders |
07/25/1995 | US5436232 Pharmaceutical composition for peritoneal dialysis |
07/25/1995 | US5436231 Hypertensive agents |
07/25/1995 | US5436009 Sustained release suppositories and a process for preparation |
07/25/1995 | US5435998 Calcium channel blocker |
07/25/1995 | US5435997 Benzoyl peroxide, aloe vera, camphor oil, shaving irritation |
07/25/1995 | US5435996 Moisturizing compositions containing organosilicon compounds |
07/25/1995 | US5435990 Chelate-antibody complexes, treatment and diagnosis of cancer, tetraazacyclododecane compounds |
07/25/1995 | EP0669824A4 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension. |
07/25/1995 | CA2140813A1 Use of flavolignans as adjuvants in tumor therapy |
07/25/1995 | CA2140722A1 Beta-carboline thromboxane synthase inhibitors |
07/25/1995 | CA2140709A1 Substituted arylureas |
07/25/1995 | CA2139909A1 Crosslinked anion exchange particles and method for producing the particles |
07/25/1995 | CA2022323C Excretion of potassium ion by prostanoic acid derivatives |
07/25/1995 | CA1336436C Gamma aminobutyric acid agonists and their use in the treatment of depression and senile dementia and other forms of memory impairment |
07/25/1995 | CA1336433C Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby |
07/25/1995 | CA1336432C N-imidazo[1,2-b]-pyridazinyl carbamates |
07/25/1995 | CA1336431C Thiazolo(5,4-b)azepine compounds |
07/25/1995 | CA1336430C Therapeutic nucleosides |
07/25/1995 | CA1336429C Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient |
07/25/1995 | CA1336428C Substituted dibenzocycloheptenimines |
07/25/1995 | CA1336412C Pharmaceutical composition having synergistic effect |
07/25/1995 | CA1336411C Veterinary composition containing cloxacillin |
07/25/1995 | CA1336410C Products containing a calcium antagonist and a lipid-lowering agent |
07/25/1995 | CA1336409C Tumor or cancer cell killing therapy and agents useful therefor |
07/25/1995 | CA1336397C Methyl cellulose pharmaceutical composition |
07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
07/21/1995 | CA2140579A1 Mono- and di-esters from cinnamic acid or one of its derivatives and vitamin c; process for preparing the same and their use as antioxidants in cosmetic, pharmaceutical or food compositions |
07/20/1995 | WO1995019434A1 Tissue-specific enhancer active in prostate |